Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v2.4.0.8
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Revenues:        
Product revenues $ 588,343 $ 850,027 $ 2,456,171 $ 1,807,653
Development service revenues   49,052 103,846 268,114
Other service revenues 44,861 28,378 84,623 28,378
Related party license revenues       650,000
Total revenues 633,204 927,457 2,644,640 2,754,145
Cost of product revenues 315,852 365,497 1,243,472 887,605
Research and development costs 873,366 725,304 2,589,410 2,238,574
Selling, general, and administrative expenses 2,062,309 1,697,876 5,792,241 5,034,514
Gain on sale of intellectual property     (4,338,601)  
Operating loss (2,618,323) (1,861,220) (2,641,882) (5,406,548)
Other income (expense):        
Gain (loss) on change in fair value of deriviative liabilities (781,157) (1,250,857) 578,179 1,328,112
Loss on note payable modification       (1,356,177)
Other income, net 38,237 39,160 167,614 406,548
Interest income 2,804 5,798 10,055 20,688
Interest expense (288,783) (127,693) (723,886) (363,115)
Net loss $ (3,647,222) $ (3,194,812) $ (2,609,920) $ (5,370,492)
Net loss per share attributable to common stockholders:        
Basic and diluted (in Dollars per share) $ (0.06) $ (0.05) $ (0.04) $ (0.09)
Weighted average shares outstanding:        
Basic and diluted (in Shares) 58,957,191 58,254,039 58,864,305 56,845,732